Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators

Details for Australian Patent Application No. 2004222097 (hide)

Owner Santhera Pharmaceuticals (Schweiz) GmbH

Inventors Weyermann, Philipp; Soeberdt, Michael; Von Sprecher, Andreas

Agent Spruson & Ferguson

Pub. Number AU-B-2004222097

PCT Pub. Number WO2004/083198

Priority 03006255.8 20.03.03 EP

Filing date 19 March 2004

Wipo publication date 30 September 2004

Acceptance publication date 7 June 2007

International Classifications

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4725 (2006.01)

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/22 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 211/70 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 217/26 (2006.01) Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/12 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/083198 Priority application(s): WO2004/083198

27 October 2005 Amendment Made

  The nature of the amendment is: Amend the invention title to read Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators

7 June 2007 Application Accepted

  Published as AU-B-2004222097

14 June 2007 Change of Name(s) of Applicant(s), Section 104

  Santhera Pharmaceuticals (Schweiz) GmbH The name of the applicant has been changed to Santhera Pharmaceuticals (Schweiz) AG

4 October 2007 Standard Patent Sealed

15 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004222098-Vibration reduction apparatus for power tool and power tool incorporating such apparatus

2004222096-Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators